WHEN SELECTING A HIGH-EFFICACY TREATMENT FOR PATIENTS WITH RELAPSING MS, START WITH TYSABRI

TYSABRI: EXPERIENCED, HIGH-EFFICACY RMS TREATMENT

More than 20 years of clinical trial and real-world experience1-3

OVER 1,000,000 PATIENT-YEARS OF EXPERIENCE

treating patients with RMS
globally, and counting1,a

Orange badge doctors icon

OVER 250,000 PATIENTS TREATED

globally for RMS with the
established therapy of
TYSABRI, and counting1,b

Blue badge globe hands icon

OVER 40% OF PATIENTS

currently prescribed in the
US have been on TYSABRI for more than 5 years1

Yellow badge calendar icon

APPROXIMATELY1 IN 3 NEW PATIENTS

in the US who start
TYSABRI have received
no previous DMT1,c

Blue badge people icon

a1,068,044 patient-years of experience as of January 2023.1
b257,071 patients treated as of January 2023.1
c37.7% of patients as of April 2021.1